BPC-157 · 10mg
Research peptideBody Protection Compound · repairs gut, tendon, ligament and muscle
Overview
What has it been researched for?
- Protects and repairs the gut lining Main focusEarly evidence
- Repairs tendon, ligament and muscleEarly evidence
- Less joint painModerate evidence
- Lowers inflammationEarly evidence
- Protects liver, bone and nervesEarly evidence
- Closes wounds and ulcersEarly evidence
- Calms an irritated bladderModerate evidence
Research protocols
The SBL research protocol and what the literature reports. Not medical advice.
SBL research protocol · no established clinical regimen in people
- Dose
- 500 mcg
- Frequency
- 1×/día
- Duration
- 4 weeks
- Route
- Subcutaneous
- Evidence level
- Human pilot
Tools
Evidence and studies
See studies →Protocols
Research protocols
SBL research protocol · no established clinical regimen in people
Research use, with no established clinical regimen in people.
- Dose
- 500 mcg
- Frequency
- 1×/día
- Timing
- cualquier hora
- Duration
- 4 weeks
- Break
- 2 weeks
- Route
- Subcutaneous
- Evidence level
- Human pilot
Example dose
30-unit U-100 insulin syringe · Starting dose of its protocol, with 2 ml of water in the 10 mg vial.
What it pairs with
Preparation and dosing
Quick reference
Preparation
- Diluent
- Bacteriostatic water
Evidence
Each effect with its evidence level and, where available, its source.
- Protects and repairs the gut liningPreclinicalSee study · 2020
- Repairs tendon, ligament and musclePreclinicalSee study · 2003
- Less joint painHuman pilotSee study · 2021
- Lowers inflammationPreclinicalSee study · 1997
- Protects liver, bone and nervesPreclinicalSee study · 2020
- Closes wounds and ulcersPreclinicalSee study · 2021
- Calms an irritated bladderHuman pilotSee study · 2024
The science
Mechanisms, studies and references
Body protective
Safety
It makes sense if you want
- General body recovery
- Recover from an injury (tendon, joint)
- Gut health & digestion
It does not make sense if
- Active cancer or oncology treatment in the last 5 years
- Pregnancy or breastfeeding
Talk to your doctor first if this applies (6)
- Anticoagulants (warfarin, rivaroxaban, etc.)
- Autoimmune disease
- Cardiovascular disease
- Hypertension
- Immunosuppressants
- Organ or bone-marrow transplant
The certificate of analysis (CoA) certifies the identity and purity of the batch. It does not certify safety of use.
Verify your batch →For research use only (RUO). This consult is educational and does not replace your doctor.
Questions
Frequently asked questions
What is it reconstituted with, and how much?
With bacteriostatic water: 2 ml into the 10 mg vial, giving 5 mg/ml.
What is the starting dose of the research protocol?
500 mcg, 1×/día. This is the SBL research protocol, with no established clinical regimen in people.
How long is the cycle, and how long does a vial last?
4 weeks ON / 2 weeks OFF. At the starting dose, the 10 mg vial lasts ~2.9 sem.
Which route is used in research?
Subcutaneous.
When does it make no sense?
It makes no sense with: Active cancer or oncology treatment in the last 5 years, Pregnancy or breastfeeding. Details in the Safety tab.
What is it combined with?
It goes well with KPV. The reasons are in the Protocols tab.
How do I check my batch?
With the code on the vial, in the verifier. The CoA certifies the identity and purity of the batch, not safety of use.
For research use only (RUO). This consult is educational and does not replace your doctor.